Leaderboard

En | De
Sie sind hier: Hämatologie » Neoplasie 20. August 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Anämie
Gerinnungsstörungen
Neoplasie
Anderes
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8488  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 169752  
   
Spontaneous lymphoproliferation differentiates two groups of HTLV-1 asymptomatic carriers: with and without high cell proliferation and death.
Immunol Res
de Souza Porto M, Mitiko T, Folgosi V, Vasconcelos D, Domingues M, Haziot M, Smid J, Marcusso R, Nukui Y, Oliveira ACP, Assone T, Casseb J, Benard G.
PMID: 42616278 [PubMed - indexed for MEDLINE]


Three decades of anaplastic lymphoma kinase: from physiological roles to cancer and immune evasion.
Cancer Metastasis Rev
Amin HM, Aminnia S, Saber MM, Kannan MK, Hung J.
PMID: 42616237 [PubMed - indexed for MEDLINE]


Prognostic value of the CONUT score in newly diagnosed diffuse large B-cell lymphoma.
Oncol Lett
Seçilmi, Afacan Öztürk HB, Ay Karaku, Dikyar A, Acar K, Güne.
PMID: 42614724 [PubMed]


Mouse models of B cell lymphomas on the basis of genetic features.
Front Immunol
Yuan M, Wang JQ.
PMID: 42614320 [PubMed - indexed for MEDLINE]


Mapping the Global Clinical Trial Landscape of Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: Current Status and Future Perspectives.
Am J Ther
Liao Y, Li Y, Feng L.
PMID: 42613665 [PubMed - as supplied by publisher]


Deep learning-based PET/CT mixture-of-experts model for relapse risk stratification in relapsed/refractory classical hodgkin lymphoma: a multicenter study.
Eur J Nucl Med Mol Imaging
Jiang C, Jiang Z, Zhang X, Zhang Z, Teng Y, Zhou H, Jiang M, Xu J, Ding C, Guo R, Li K, Tian R.
PMID: 42613444 [PubMed - as supplied by publisher]


Nutritional outcomes associated with enteral versus parenteral nutritional support during intensive induction chemotherapy for acute myeloid leukemia.
Support Care Cancer
Schwarz M, Lebreton A, Lester MA, Marchand T, Houot R, Giltat A, Mokeddem C, Mear JB, Darras E, Orvain C, Hunault M, Tanguy-Schmidt A.
PMID: 42613390 [PubMed - indexed for MEDLINE]


Prognostic Impact of Sequential Measurable Residual Disease and KIT Variant Status in Pediatric Core-Binding Factor Acute Myeloid Leukemia: A Retrospective Multicenter Study of the Taiwan Pediatric Oncology Group.
Ann Lab Med
Yeh TC, Jaing TH, Liu HC, Chen SH, Wang SC, Hsiao CC, Chiou SS, Hou JY, Lin PC, Huang FL, Yang SH, Huang TY, Yang CP, Shih LY.
PMID: 42613183 [PubMed - as supplied by publisher]


Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study.
Br J Haematol
Kim WS, Kim SJ, Jo JC, Yoon SE, Koh Y, Yang DH, Yoon DH, Cho J, Lee SY, Kim S, Kang S, Hwang W, Kim H, Yun HY, Jeon J, Ahn C, Kim HT.
PMID: 42613033 [PubMed - as supplied by publisher]


Standardized Multicolor Flow Cytometry Protocol for Measurable Residual Disease Assessment in Acute Leukemia.
J Vis Exp
Li L.
PMID: 42611945 [PubMed - indexed for MEDLINE]


Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia.
Leuk Lymphoma
DeAngelo DJ, Chen Y, Cassaday RD, Hibma JE, Yang DZ, Garrett M, Zhang F, Dimitrov SH, Vandendries ER, Kantarjian HM.
PMID: 42611806 [PubMed - as supplied by publisher]


Erythroblastic sarcoma with biallelic TP53 mutations and novel NUP214:: ABL1-new finding in erythroblastic sarcoma/acute erythroid leukemia.
J Hematop
Manzo R, Xia C, Tang Z, Khoury JD, Zhang S.
PMID: 42611361 [PubMed - indexed for MEDLINE]


Quantitative Integration of Targeted and Nontargeted Metabolomics Using Multi-Stable Isotope Chemical Tagging with UHPLC-QToF MS: Application to Myeloid Leukemia Metabolism.
Anal Chem
Takayama T, Tsutsumi T, Higuchi T, Takahashi S, Hayashi Y, Inoue K.
PMID: 42610920 [PubMed - indexed for MEDLINE]


Blinatumomab administration in the outpatient setting: Safety and health care utilization.
Cancer
Valtis YK, Frost BF, Nemirovsky D, Derkach A, Chin KK, Salman MY, Boussi L, Ovalle NT, Baxter E, Mercurio A, Stein EM, Geyer MB, Schrag D, Kelkar AH, DeAngelo DJ, Luskin MR, Park JH, Chen EC.
PMID: 42610826 [PubMed - indexed for MEDLINE]


Therapeutic Exercise Protocol During Hospitalization in Pediatric Oncohematological Patients: Randomized Clinical Trial.
Physiother Res Int
Carniel CF, Souza BC, Leite HF, Zangirolami-Raimundo J, Raimundo RD.
PMID: 42610644 [PubMed - indexed for MEDLINE]


Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.
Haematologica
Backhaus D, Bischof L, Jendro J, Ussmann J, Brauer D, Herling M, Vucinic V, Franke GN, Platzbecker U, Cross M, Metzeler KH, Schwind S, Jentzsch M.
PMID: 42610424 [PubMed - as supplied by publisher]


Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.
Haematologica
Renaud L, Chaillol I, Galtier J, Bommier C, Tessoulin B, De Colella JMS, Lamy T, Borel C, Stamatoullas A, Gac AC, Morschhauser F, Andre M, Ghesquieres H, Traverse-Glehen A, Casasnovas O, Gastine T.
PMID: 42610414 [PubMed - as supplied by publisher]


Acute Myeloid Leukemia Survivors Report Transplant-specific Burdens in Interviews Two Years after Receiving Allogeneic Hematopoietic Cell Transplantation During the Peak of the COVID-19 Pandemic: A Qualitative Study.
Inquiry
McAndrew NS, Patterson S, Mohanraj L, Awoyinka I, Costanzo ES, Cole SW, Knight JM.
PMID: 42610368 [PubMed - indexed for MEDLINE]


Diagnostic Potential of microRNAs in Leukemia: a Review of Current Evidence.
Clin Lab
Alsanawi AA, Naes SM, Alhoot MA, Shaikh SS, AlDarwish MHM, Aljassim THM, Altammar MAH, Alkhabbaz AM, Alzarra FJ.
PMID: 42609709 [PubMed - indexed for MEDLINE]


Efficacy of BEAM versus BeEAM conditioning regimens in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: a retrospective single-center study.
Front Oncol
Akebaer S, Chen G, Xu J, Zhang K, Yang R, Han C, Hou J, Jiang M, Yuan H.
PMID: 42609647 [PubMed]


   
   Artikel 1 - 20 / 169752    Seite 1 von 8488  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1